The yearly session of the Commission on Narcotic Drugs is a weird kind of meeting. Almost permanently, four kinds of sessions are going on at the same time: the plenary; a committee with the puzzling name “committee of the whole”; “other meetings”; and “side events”.
For me, coming in there as an individual, it was hard to know what was going on, where and when. Gradually I learned that the member states’ delegations and most of the attending organizations were prepared from the start, so that every member delegate knew where and when she/he had to be, taking turns at specific meetings to be able to keep track or make notes of the rare moments that something of substance was eventually being said.